NCT00045149已完成1 期
Phase I Study to Evaluate the Safety of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen Specific T Cell Clones Targeting Cancer Testis Antigens for Patients With Metastatic Melanoma
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
RATIONALE: Biological therapies such as cellular adoptive immunotherapy use different ways to stimulate the immune system and stop cancer cells from growing. Treating a person's white blood cells in the laboratory and then reinfusing them may cause a stronger immune response and kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of biological therapy in treating patients who have metastatic melanoma.
详细描述
OBJECTIVES:
Primary
- Determine the safety and toxicity of cellular adoptive immunotherapy comprising autologous CD8+ cytotoxic T-lymphocyte clones targeting cancer-testis antigens in patients with metastatic melanoma.
- Determine the duration of in vivo persistence of this therapy in these patients.
Secondary
- Evaluate the antitumor effects of this therapy in these patients.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV MelanomaMelanoma (Skin)NCT00317759Fred Hutchinson Cancer Center12
已完成
1 期
Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal CancerPeritoneal Cavity CancerOvarian CancerNCT00101257Fred Hutchinson Cancer Center18
已完成
1 期
Biological Therapy in Treating Patients With Metastatic MelanomaMelanoma (Skin)NCT00045357Fred Hutchinson Cancer Center18
已完成
1 期
Biological Therapy in Treating Patients With Metastatic MelanomaMelanoma (Skin)NCT00002786Fred Hutchinson Cancer Center20
已完成
1 期
Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant GliomaBrain and Central Nervous System TumorsNCT00730613City of Hope Medical Center3